Pharmaron Beijing Co Ltd
SZSE:300759
Pharmaron Beijing Co Ltd
SZSE:300759
Price:
19.75 CNY
-1%
Market Closed
Updated:
May 3, 2024
Pharmaron Beijing Co Ltd
Cash from Investing Activities
|
Pharmaron Beijing Co Ltd
Cash from Investing Activities Peer Comparison
Comparables:
603259
2269
300347
1548
W
2268
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Investing Activities
-¥2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Investing Activities
-¥7.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Investing Activities
-¥5.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Investing Activities
-¥1.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-27%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Cash from Investing Activities
-$561m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Cash from Investing Activities
-¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharmaron Beijing Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.3B
CNY
-2.3B
CNY
Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Cash from Investing Activities amounts to -2.3B CNY.
What is Pharmaron Beijing Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-26%
-26%
Over the last year, the Cash from Investing Activities growth was -2%. The average annual Cash from Investing Activities growth rates for Pharmaron Beijing Co Ltd have been 13% over the past three years , -26% over the past five years .
You don't have any saved screeners yet
